A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice

[1]  F. Fedele,et al.  Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring , 2021, Cardiac Electrophysiology Clinics.

[2]  G. Boriani,et al.  Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2021, Journal of clinical medicine.

[3]  M. Ziacchi,et al.  Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management , 2021, Circulation. Heart failure.

[4]  C. Lavalle,et al.  Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown , 2021, Pacing and clinical electrophysiology : PACE.

[5]  F. Fedele,et al.  Sporadic High Pacing and Shock Impedance at Remote Monitoring in Hybrid Implantable Cardioverter Defibrillators Systems: Clinical Impact and Management. , 2021, Heart rhythm.

[6]  J. Burkhardt,et al.  Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience , 2020, Journal of Interventional Cardiac Electrophysiology.

[7]  G. Boriani,et al.  Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2020, Internal and Emergency Medicine.

[8]  A. Natale,et al.  Creating a safe workplace by universal testing of SARS-CoV-2 infection in patients and healthcare workers in the electrophysiology unit having no symptoms of COVID-19: a multi-center experience , 2020, medRxiv.

[9]  F. Fedele,et al.  Management of cardiac implantable electronic device follow‐up in COVID‐19 pandemic: Lessons learned during Italian lockdown , 2020, Journal of cardiovascular electrophysiology.

[10]  Dhanunjaya R. Lakkireddy,et al.  HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic , 2020, Journal of the American College of Cardiology.

[11]  Dhanunjaya R. Lakkireddy,et al.  Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat , 2020, Heart Rhythm.

[12]  N. Mercuri,et al.  Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording , 2019, Journal of Interventional Cardiac Electrophysiology.

[13]  M. Pombo,et al.  Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) , 2019, European heart journal.

[14]  J. Morgan,et al.  Remote management of heart failure using implantable electronic devices , 2017, European heart journal.

[15]  G. Hindricks,et al.  Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) , 2017, European heart journal.

[16]  Renato Pietro Ricci,et al.  HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.

[17]  R. Mahajan,et al.  Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes. , 2015, Journal of the American College of Cardiology.

[18]  S. Normand,et al.  Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators , 2015, Circulation. Arrhythmia and electrophysiology.

[19]  G. Mairesse,et al.  Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[21]  S. Chaudhry,et al.  Use of Remote Monitoring of Newly Implanted Cardioverter-Defibrillators: Insights From the Patient Related Determinants of ICD Remote Monitoring (PREDICT RM) Study , 2013, Circulation.

[22]  F. Romeo,et al.  Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system , 2013, Journal of cardiovascular medicine.

[23]  Cristina Masella,et al.  CONSORT-EHEALTH Checklist V1.6.2 Report , 2013 .

[24]  G. Baumann,et al.  Workload and usefulness of daily, centralized home monitoring for patients treated with CIEDs: results of the MoniC (Model Project Monitor Centre) prospective multicentre study. , 2013, Europace.

[25]  Niraj Varma,et al.  Remote monitoring of cardiovascular devices: a time and activity analysis. , 2012, Heart rhythm.

[26]  R. Hauser,et al.  Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. , 2012, Heart rhythm.

[27]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[28]  Philippe Mabo,et al.  A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) , 2011, European heart journal.

[29]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[30]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[31]  A. de Silvestri,et al.  A meta-analysis of remote monitoring of heart failure patients. , 2009, Journal of the American College of Cardiology.

[32]  M. Linnaluoto,et al.  Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  W. Maisel,et al.  Semper fidelis--consumer protection for patients with implanted medical devices. , 2008, The New England journal of medicine.